J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M300214-JLR200 on October 16, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300214-JLR200v1
45/1/124    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cianflone, K.
Right arrow Articles by Sniderman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cianflone, K.
Right arrow Articles by Sniderman, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 45, 124-131, January 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology

Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance

Katherine Cianflone1,*, Robert Zakarian*, Charles Couillard{dagger}, Bernadette Delplanque§, Jean-Pierre Despres{dagger} and Allan Sniderman*

* Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Royal Victoria Hospital, 687 Pine Avenue, West Montreal, Quebec H3A 1A1, Canada
{dagger} Lipid Research Centre, Centre Hospitalier Universitaire de Québec Research Centre and Department of Food Sciences and Nutrition, Laval University, Sainte-Foy, Canada
§ Laboratoire de Physiologie et de la Nutrition, Universite Paris Sud, Orsay, France

1 To whom correspondence should be addressed. e-mail: katherine.cianflone{at}mcgill.ca

Postprandial plasma triglyceride (ppTG) and NEFA clearance were stratified by plasma acylation-stimulating protein (ASP) and gender to determine the contribution of fasting ASP in a normal population (70 men; 71 women). In the highest ASP tertile only, ASP decreased over 8 h (90 ± 9.7 nM to 70 ± 5.9 nM, P < 0.05 males; 61.9 ± 4.0 nM to 45.6 ± 6.2 nM, P < 0.01 females). Fasting ASP correlated positively with ppTG response. ppTG (P < 0.0001, 2-way ANOVA, both genders) and NEFA levels progressively increased from lowest to highest ASP tertile, with the greatest differences in males. By stepwise multiple regression, the best prediction of ppTG was: (fasting ASP + apolipoprotein B + insulin + TG; r = 0.806) for men and (fasting ASP + total cholesterol; r = 0.574) for women. Leptin, body mass index, and other fasting variables did not improve the prediction. Thus, in men and women, ASP significantly predicted ppTG and NEFA clearance and, based on lower ASP, women may be more ASP sensitive than men.

Plasma ASP may be useful as a fasting variable that will provide additional information regarding ppTG and NEFA clearance.

Abbreviations: ASP, acylation-stimulating protein; BMI, body mass index; HOMA, homeostatic model of insulin resistance; iAUC, incremental area under the curve; RM-ANOVA, repeated measures analyses of variance; TG, triglyceride

Supplementary key words C3adesArg • fatty acid • insulin • leptin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone
Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E521 - E529.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone
Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1482 - E1491.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Marcil, H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest Jr, and K. Cianflone
Identification of a Novel C5L2 Variant (S323I) in a French Canadian Family With Familial Combined Hyperlipemia
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1619 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone
Targeting the signaling pathway of acylation stimulating protein
J. Lipid Res., March 1, 2006; 47(3): 643 - 652.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.